NCT02516241 2026-04-20Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial CancerAstraZenecaPhase 3 Active not recruiting1,126 enrolled 52 charts
NCT03390504 2026-04-13THORJanssen Research & Development, LLCPhase 3 Active not recruiting629 enrolled 32 charts